We hypothesized that NOX2 might be involved in the neurite outgrowth of CGN because NOX2 is expressed in growth cones, and NOX inhibitors partially decreased the expression of Tau and MAP2. The gene discussed is MAP2; the disease is childhood gender nonconformity.